Clinical Trial Update: The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of an investigational Alzheimer's disease drug sponsored by Merck was terminated; no efficacy or safety resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Alzheimer Disease | Phase 3 | Status: TERMINATED